HIGHLIGHTS
- who: John Kerr White from the Department of Microbiology, Tumor and Cell Biology, Division of Clinical Microbiology, Karolinska University have published the paper: A stable cyclized antimicrobial peptide derived from LL-37 with host immunomodulatory effects and activity against uropathogens, in the Journal: (JOURNAL)
- what: The authors demonstrate the potential of the synthetic peptide designed by dimerization and backbone cyclization of the shortest antimicrobial region of human cathelicidin LL-37. is active against clinical and type strains of common uropathogens Escherichia coli Klebsiella pneumoniae and Pseudomonas aeruginosa at concentrations substantially below cellular cytotoxic levels and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.